These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 8430324

  • 81. First grants for innovative AIDS vaccine research awarded.
    Parrott C.
    NIAID AIDS Agenda; 1997 Nov; ():5-7. PubMed ID: 11364922
    [Abstract] [Full Text] [Related]

  • 82. Science and the control of AIDS.
    Varmus H, Nathanson N.
    Science; 1998 Jun 19; 280(5371):1815. PubMed ID: 9669926
    [No Abstract] [Full Text] [Related]

  • 83. Panel urges NIH to loosen its grip on AIDS research.
    Cohen J.
    Science; 1996 Mar 15; 271(5255):1491. PubMed ID: 8599099
    [No Abstract] [Full Text] [Related]

  • 84. AIDS funding. MicroGeneSys vaccine trial gets a public peer review.
    Cohen J.
    Science; 1992 Nov 13; 258(5085):1079-80. PubMed ID: 1439814
    [No Abstract] [Full Text] [Related]

  • 85. Call for governments to back development of AIDS vaccine.
    Dickson D.
    Nature; 1999 Sep 02; 401(6748):4. PubMed ID: 10485690
    [No Abstract] [Full Text] [Related]

  • 86. New frontiers of immunotherapy for HIV.
    Haynes BF.
    Lancet; 1996 Dec 07; 348(9041):1531-2. PubMed ID: 8950876
    [No Abstract] [Full Text] [Related]

  • 87. Global AIDS trial denied patients as US balks at generic drug use.
    Check E.
    Nature; 2004 Sep 30; 431(7008):493. PubMed ID: 15457219
    [No Abstract] [Full Text] [Related]

  • 88. FDA panel reluctantly approves AIDS vaccine trial.
    Fox JL.
    Nat Med; 1995 Mar 30; 1(3):191-2. PubMed ID: 7585025
    [No Abstract] [Full Text] [Related]

  • 89. Hope in a vial. Will there be an AIDS vaccine anytime soon?
    Ezzell C.
    Sci Am; 2002 Jun 30; 286(6):38-45. PubMed ID: 12030090
    [No Abstract] [Full Text] [Related]

  • 90. One for the money.
    Mandavilli A.
    Nat Med; 2005 Jun 30; 11(6):587-8. PubMed ID: 15937461
    [No Abstract] [Full Text] [Related]

  • 91. HIV-1/AIDS vaccine development: are we in the darkness.
    Qiu C, Xu JQ.
    Chin Med J (Engl); 2008 May 20; 121(10):939-45. PubMed ID: 18706210
    [No Abstract] [Full Text] [Related]

  • 92. NIAID collaborates with VaxGen on vaccine studies.
    AIDS Patient Care STDS; 1998 Nov 20; 12(11):874. PubMed ID: 11362049
    [No Abstract] [Full Text] [Related]

  • 93. 14th International AIDS Conference--Barcelona 7-12 July 2002.
    Moodley K.
    SADJ; 2002 Dec 20; 57(11):441-2. PubMed ID: 12674859
    [No Abstract] [Full Text] [Related]

  • 94. [Several aspects of HIV infections].
    Costantino M.
    Minerva Chir; 1991 Oct 31; 46(20):1152. PubMed ID: 1766567
    [No Abstract] [Full Text] [Related]

  • 95. NIH opens first trial of HIV vaccines in children.
    Infect Control Hosp Epidemiol; 1993 Jun 31; 14(6):352. PubMed ID: 8360467
    [No Abstract] [Full Text] [Related]

  • 96. AIDS research. Vaccine studies stymied by shortage of animals.
    Cohen J.
    Science; 2000 Feb 11; 287(5455):959-60. PubMed ID: 10691568
    [No Abstract] [Full Text] [Related]

  • 97.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 98. Low-cost anti-HIV compounds: potential application for AIDS therapy in developing countries.
    Bourinbaiar AS, Jirathitikal V.
    Curr Pharm Des; 2003 Feb 11; 9(18):1419-31. PubMed ID: 12769722
    [Abstract] [Full Text] [Related]

  • 99. Xenotransplantation at a crossroads: prevention versus progress.
    Allan JS.
    Nat Med; 1996 Jan 11; 2(1):18-21. PubMed ID: 8564824
    [Abstract] [Full Text] [Related]

  • 100. African AIDS vaccine programme for a coordinated and collaborative vaccine development effort on the continent.
    Kaleebu P, Abimiku A, El-Halabi S, Koulla-Shiro S, Mamotte N, Mboup S, Mugerwa R, Nkengasong J, Toure-Kane C, Tucker T, Wassenaar D, Williamson C, Wolday D.
    PLoS Med; 2008 Dec 02; 5(12):e236. PubMed ID: 19053171
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.